The male mortality from cvd, cancer, diabetes or crd between exact ages 30 and 70 in Tunisia remains constant at 19.2%, unmoved since 2018.
Male mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 in Tunisia
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2019
Points:
13,760
Measure:
%
Similar regions to Tunisia
Male CVD, cancer, diabetes or CRD
More indicators for Tunisia
Out-of-pocket expenditure PPP per capita
intl dollar265
+intl dollar15
(2021)
Newborns protected against tetanus
98%
+1%
(2022)
Female wasting in children
2.1%
+0.3%
(2018)
Birth registration
99.9%
+0.9%
(2018)
Female prevalence of HIV
0.1%
0%
(2022)
Contraceptive modern method prevalence
44.3%
-6.6%
(2018)
Tunisia Male CVD, cancer, diabetes or CRD between 2000 and 2019
| Period | Male CVD, cancer, diabetes or CRD | Change |
|---|---|---|
| 2019 | 19.2% | 0% |
| 2018 | 19.2% | 0% |
| 2017 | 19.2% | 0% |
| 2016 | 19.2% | -0.1% |
| 2015 | 19.3% | -0.2% |
| 2014 | 19.5% | -0.2% |
| 2013 | 19.7% | -0.2% |
| 2012 | 19.9% | -0.2% |
| 2011 | 20.1% | -0.1% |
| 2010 | 20.2% | -0.2% |
| 2009 | 20.4% | -0.2% |
| 2008 | 20.6% | -0.2% |
| 2007 | 20.8% | -0.2% |
| 2006 | 21% | -0.3% |
| 2005 | 21.3% | -0.2% |
| 2004 | 21.5% | -0.3% |
| 2003 | 21.8% | -0.5% |
| 2002 | 22.3% | -0.2% |
| 2001 | 22.5% | -0.3% |
| 2000 | 22.8% |